Reuters logo
BRIEF-FDA accepts Roche filing for Avastin in advanced ovarian cancer
October 26, 2017 / 5:09 AM / a month ago

BRIEF-FDA accepts Roche filing for Avastin in advanced ovarian cancer

Oct 26 (Reuters) - Roche Holding AG

* Says FDA accepts Roche’s supplemental biologics license application for Avastin as a front-line treatment for women with advanced ovarian cancer Source text for Eikon: Further company coverage: (Reporting By Michael Shields)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below